The FDA has officially cleared the Dexcom G5 continuous glucose monitor to inform treatment decisions -- without the use of a fingerstick glucometer, other than for calibration. The G5 has been ...

Usually when someone says they’ve done something more than 3,000 times, they're exaggerating. But when it comes to fingersticks, for people with diabetes, that's probably true. Dexcom’s latest DTC ...

Dexcom has long envisioned a future where patients with diabetes don't need confirmatory fingersticks to make decisions about their treatment. Now, that future may be one step closer than before. The ...

For the first time, the US Food and Drug Administration has approved the use of a continuous glucose monitoring (CGM) system to replace finger-stick testing for determining insulin doses. The decision ...

On the day of the approval, top FDA and CMS officials write in JAMA of the need to share data for better healthcare delivery. The FDA today expanded its approval for Dexcom’s G5 mobile continuous ...

Continuous glucose monitors (CGMs) could enhance care of hospitalized people with diabetes, supplementing or possibly even replacing the use of finger sticks to draw blood to measure a patient's ...

There are various blood sugar monitors for people with diabetes. Some devices may require individuals to regularly prick their fingers, while others only require finger pricking for calibration ...

Please provide your email address to receive an email when new articles are posted on . Adults with type 1 diabetes using intermittently scanned CGM had a greater HbA1c reduction than those using ...

Dexcom has launched what is being called the first-ever over-the-counter continuous glucose monitoring system. The San Diego, CA-based company’s Stelo was cleared by FDA earlier this year and will go ...